Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Rev Latinoam Microbiol ; 40(3-4): 128-34, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-10932741

RESUMO

Seventy strains of Staphylococcus aureus isolated from the nasopharynx (80%), urinary tract (16%), skin (1 strain) and eyes (2 strains) of patients at the clinical laboratory "El eritrocito" were analyzed. Susceptibility to 12 antibiotics was tested by the method of Kirby-Bauer. Minimal inhibitory concentration (MIC) of ampicillin, ampicillin + sulbactam, amoxicillin and amoxicillin + clavulanic acid were determined by plate dilution. Percentages of resistance were: Penicillin and ampicillin (100%), ceftazidime (81.4%), erythromycin (68.6%), tetracycline (31.4%) trimethoprim-sulphametoxasol (25.7%), dicloxacillin and pefloxacin (12.8%), cefuroxime and cefotaxime (4.3%), gentamicin (2.8%), cephalothin (0%). All strains were resistant to three or more antibiotics, with higher percentages of resistance to four (31.4%), three (27.1%), five (21.4%) and six (12.9%) drugs. One strain was resistant to nine antibiotics and 5.9% were resistant to seven. 97.5% of the strains were beta-lactamase-positive. The MIC50 of ampicillin and amoxicillin was 500 micrograms/ml and the MIC90 were 1727 micrograms/ml and 2000 micrograms/ml, respectively. beta-lactamase inhibitors sulbactam and clavulanic acid reduced these values eightfold, except for the MIC50 of ampicillin + sulbactam whose reduction was sixteen fold. These results show that the combination of beta-lactamic + beta-lactamase inhibitor was more efficient than cephalosporins for killing these beta-lactamase-positive strains.


Assuntos
Amoxicilina/farmacologia , Ampicilina/farmacologia , Proteínas de Bactérias/antagonistas & inibidores , Ácido Clavulânico/farmacologia , Inibidores Enzimáticos/farmacologia , Staphylococcus aureus/efeitos dos fármacos , Sulbactam/farmacologia , Inibidores de beta-Lactamases , 4-Quinolonas , Aminoglicosídeos , Antibacterianos/farmacologia , Anti-Infecciosos/farmacologia , Cefalosporinas/farmacologia , Resistência Microbiana a Medicamentos , Resistência a Múltiplos Medicamentos , Quimioterapia Combinada/farmacologia , Macrolídeos , Testes de Sensibilidade Microbiana , Penicilinas/farmacologia , Staphylococcus aureus/enzimologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA